Atossa Therapeutics

(NASDAQ) ATOS

Current Price$5.21

Market Cap$45.90M

Since IPO (2012)-100%

5 Year-85%

1 Year-58%

1 Month+4%

Atossa Therapeutics Financials at a Glance

Market Cap

$45.90M

Revenue (TTM)

$0.00

Net Income (TTM)

$34.77M

EPS (TTM)

$-4.04

P/E Ratio

-1.32

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Price

$5.21

Volume

262

Open

$5.37

Price

$5.21

Volume

262

Open

$5.37

Previous Close

$5.21

Daily Range

$5.21 - $5.37

52-Week Range

$3.76 - $19.35

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Price

$5.21

Volume

262

Open

$5.37

Previous Close

$5.21

Daily Range

$5.21 - $5.37

52-Week Range

$3.76 - $19.35

ATOS News

smart-doctor-contemplating-your-question-getty

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Atossa Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Steven C. Quay, MD, PhD

Website

www.atossatherapeutics.com

Headquarters

Seattle, WA 98104, US

ATOS Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-63%

Return on Capital

-94%

Return on Assets

-73%

Earnings Yield

-75.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$45.90M

Shares Outstanding

8.61M

Volume

262

Avg. Volume

110.93K

Financials (TTM)

Gross Profit

$16.00K

Operating Income

$37.14M

EBITDA

$37.13M

Operating Cash Flow

$29.76M

Capital Expenditure

$23.00K

Free Cash Flow

$29.79M

Cash & ST Invst.

$41.30M

Total Debt

$0.00

Atossa Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$4.00K

+0.0%

Gross Margin

0.00%

N/A

Market Cap

$45.90M

N/A

Market Cap/Employee

$3.06M

N/A

Employees

N/A

Net Income

$10.94M

-72.3%

EBITDA

$11.43M

-60.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$41.30M

-41.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-73.03%

N/A

Return on Invested Capital

-94.38%

N/A

Free Cash Flow

$10.55M

-49.6%

Operating Cash Flow

$10.54M

-49.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TILInstil Bio, Inc.

TILInstil Bio, Inc.$7.90-1.00%

CLNNClene Inc.

CLNNClene Inc.$6.14-0.32%

TVGNTevogen Bio Holdings Inc.

TVGNTevogen Bio Holdings Inc.$6.66+0.30%

COYACoya Therapeutics, Inc.

COYACoya Therapeutics, Inc.$4.17-1.42%

ONCYOncolytics Biotech Inc.

ONCYOncolytics Biotech Inc.$0.87-1.13%

CGTXCognition Therapeutics, Inc.

CGTXCognition Therapeutics, Inc.$1.28+1.59%

WHWKWhitehawk Therapeutics Inc

WHWKWhitehawk Therapeutics Inc$3.99-0.50%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About ATOS

What is the current price of Atossa Therapeutics?

Atossa Therapeutics is trading at $5.21 per share.

What is the 52-week range for Atossa Therapeutics?

Over the past 52 weeks, Atossa Therapeutics has traded between $3.76 and $19.35.

How much debt does Atossa Therapeutics have?

As of the most recent reporting period, Atossa Therapeutics reported total debt of N/A.

How much cash does Atossa Therapeutics have on hand?

Atossa Therapeutics reported $41.41M in cash and cash equivalents in its most recent financial results.

What is Atossa Therapeutics’s dividend yield?

Atossa Therapeutics does not currently have a dividend yield.

Atossa Therapeutics

Atossa Therapeutics Financials at a Glance

ATOS News

Can Atossa Therapeutics Stock Keep Climbing?

Why Atossa Therapeutics Stock Is Jumping Today

Why Atossa Therapeutics Stock Is Tumbling Today

Why Atossa Therapeutics Blasted 30% Higher on Monday

Why Atossa Therapeutics Soared 20% Higher Today

Why Atossa Therapeutics Stock Soared Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Atossa Therapeutics

ATOS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Atossa Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ATOS

What is the current price of Atossa Therapeutics?

What is the 52-week range for Atossa Therapeutics?

How much debt does Atossa Therapeutics have?

How much cash does Atossa Therapeutics have on hand?

What is Atossa Therapeutics’s dividend yield?

Premium Investing Services